Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies


March 19, 2013
5072 Pages - SKU: BIOS5014693
License type:
Table of Contents Related Reports
CompetitiveWatch Infectious Disease Testing: Strategic Profiles of Leading Suppliers
5/14/2013 | published by: Venture Planning Group
This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography  |  read more...
$3,500.00
Monoclonal Antibody Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for monoclonal antibody has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends,  |  read more...
$2,000.00
Analytical Tool - Apoptosis in Oncology
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool - Apoptosis in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is at the same  |  read more...
$11,625.00
Analytical Tool - Antibodies and Peptides in Oncology
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool – Antibodies and Peptides in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and peptide cancer drug  |  read more...
$22,312.50
Analytical Tool - Cancer Immunotherapy
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool- Cancer Immunotherapy offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It is at the same time a  |  read more...
$20,437.50
Analytical Tool - Cancer Therapeutic Antibodies
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool - Cancer Therapeutic Antibodies offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. It is at the same  |  read more...
$14,808.75
Antibodies in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
Antibodies in Oncology Drug Pipeline Update 2013 The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of  |  read more...
$5,621.25
Cancer Monoclonal Antibody Partnering Agreements - CP22012 - May2013v3
5/1/2013 | published by: Current Partnering
The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in  |  read more...
$1,995.00
Cancer Vaccines Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
Cancer Vaccines Drug Pipeline Update 2013 Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has proved elusive, leaving  |  read more...
$5,621.25
Analytical Tool - Cancer Vaccines
4/22/2013 | published by: BioSeeker Group AB
Analytical Tool - Cancer Vaccines offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same time a map of the  |  read more...
$11,625.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Cancer Vaccines Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!